Also trades as: 0QMV.L (LSE) · $vol 16M · 0QMV.IL (IOB) · $vol 15M · SAUHY (OTC) · $vol 1M · SAUHF (OTC) · $vol 0M

CHF 89.80 ($108.39)

-1.74 (-1.90%)

Weekly Expected Move ±3.1%

CHF 84 CHF 87 CHF 90 CHF 93 CHF 95

SIX · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 40 · CHF 14.3B mcap · 108M float · 0.333% daily turnover

Revenue

$2.6B +4.0% ▲

5Y CAGR: +12.8%

Gross Profit

$1.8B +0.2% ▲

5Y CAGR: +11.7%

Operating Income

$549M -8.7% ▼

5Y CAGR: +11.7%

Net Income

$358M -7.8% ▼

5Y CAGR: +31.4%

EPS (Diluted)

$2.24 -8.2% ▼

5Y CAGR: +31.5%

EBITDA

$549M -24.4% ▼

5Y CAGR: +19.0%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.0B	$2.3B	$2.4B	$2.5B	$2.6B
YoY Growth	+41.8%	+14.8%	+3.9%	+3.8%	+4.0%
Cost of Revenue	$493M	$620M	$623M	$721M	$818M
Gross Profit	$1.5B	$1.7B	$1.8B	$1.8B	$1.8B
Gross Margin	75.6%	73.3%	74.2%	71.2%	68.6%
R&D Expenses	$96M	$105M	$0	$116M	$0
SG&A Expenses	$1.0B	$1.2B	$1.4B	$1.2B	$0
Operating Expenses	$993M	$1.2B	$1.4B	$1.2B	$1.2B
Operating Income	$537M	$530M	$411M	$601M	$549M
Operating Margin	26.5%	22.9%	17.0%	24.0%	21.1%
Interest Expense	$17M	$17M	$15M	$22M	$0
Income Before Tax	$471M	$506M	$346M	$560M	$0
Tax Expense	$78M	$64M	$99M	$100M	$0
Net Income	$396M	$435M	$246M	$388M	$358M
Net Margin	19.6%	18.7%	10.2%	15.5%	13.7%
EPS (Diluted)	$2.48	$2.72	$1.54	$2.44	$2.24
EBITDA	$591M	$678M	$495M	$726M	$549M
Shares Outstanding	160M	160M	160M	160M	160M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$1.1B	$1.2B	$1.2B	$1.3B	$1.2B	$1.3B	$1.3B	$1.4B
Cost of Revenue	$332M	$306M	$333M	$353M	$374M	$376M	$442M	$395M
Gross Profit	$811M	$911M	$862M	$920M	$857M	$972M	$818M	$985M
Gross Margin	71.0%	74.9%	72.1%	72.2%	69.6%	72.1%	65.1%	71.4%
R&D Expenses	$105M	$0	$111M	$0	$116M	$0	$0	$0
SG&A Expenses	$602M	$618M	$751M	$588M	$600M	$622M	$627M	$633M
Operating Expenses	$602M	$618M	$751M	$584M	$600M	$642M	$597M	$642M
Operating Income	$208M	$293M	$111M	$336M	$256M	$330M	$208M	$342M
Operating Margin	18.2%	24.1%	9.3%	26.4%	20.8%	24.4%	16.6%	24.8%
Interest Expense	$69M	$77M	$90M	$94M	$101M	$112M	$76M	$74M
Income Before Tax	$188M	$260M	$95M	$325M	$235M	$293M	$163M	$313M
Tax Expense	$13M	$49M	$49M	$56M	$44M	$54M	$43M	$63M
Net Income	$169M	$206M	$40M	$230M	$156M	$236M	$120M	$251M
Net Margin	14.8%	16.9%	3.4%	18.1%	12.7%	17.5%	9.5%	18.2%
EPS (Diluted)	$1.06	$1.29	$0.25	$1.44	$0.98	$1.49	$0.76	$1.57
EBITDA	$330M	$400M	$252M	$409M	$416M	$434M	$262M	$424M
Shares Outstanding	159M	160M	159M	159M	160M	160M	158M	160M

STMN.SW SIX